Table 3.
Post- op h | 0-2 (h) |
2-12 (h) |
12-24 (h) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Group I n (%) | Group II n (%) | P | Group I n (%) | Group II n (%) | P | Group I n (%) | Group II n (%) | P | |||
Emetic episodes | 0 | 47 (79.7%) | 52 (85.2%) | 0.49* | 51 (86.4%) | 52 (85.2%) | 0.97# | 59 (100%) | 58 (95.0%) | 0.23* | |
1-2 | 11 (18.7%) | 9 (14.7%) | 6 (10.1%) | 7 (11.4%) | 0 | 3 (4.9%) | |||||
>2 | 1 (1.6%) | 0 | 2 (3.3%) | 2 (3.2%) | 0 | 0 | |||||
Nausea VRS | 0 | 47 (79.6%) | 51 (83.6%) | 0.84# | 48 (81.3%) | 46 (75.4%) | 0.73# | 57 (96.6%) | 57 (93.4%) | 0.62# | |
1-2 | 2 (3.3%) | 2 (3.2%) | 3 (5.0%) | 4 (6.5%) | 1 (1.6%) | 1 (1.6%) | |||||
>2 | 18 (30.5%) | 8 (13.1%) | 8 (13.5%) | 11 (18.0%) | 1 (1.6%) | 3 (4.9%) |
VRS – Verbal Rating Score, *P is obtained from Yate’s continuity correction; #P is obtained from Fisher’s exact test